BlackRock Investment Management’s PDL BioPharma, Inc. PDLI Stock Holding History

BlackRock Investment Management’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.43M	Sell	675,286 -9,810	-1%	-$27.4K	﹤0.01%	2453
2016 Q3	$2.29M	Sell	685,096 -2,882	-0.4%	-$9.15K	﹤0.01%	2047
2016 Q2	$2.16M	Buy	687,978 +72,358	+12%	+$241K	﹤0.01%	2034
2016 Q1	$2.05M	Buy	615,620 +662	+0.1%	+$2.06K	﹤0.01%	1990
2015 Q4	$2.18M	Buy	614,958 +1,716	+0.3%	+$7.18K	﹤0.01%	2016
2015 Q3	$3.08M	Buy	613,242 +3,816	+0.6%	+$21.9K	﹤0.01%	1726
2015 Q2	$3.92M	Buy	609,426 +162,302	+36%	+$1.09M	﹤0.01%	1692
2015 Q1	$3.15M	Buy	447,124 +6,947	+2%	+$50.3K	﹤0.01%	1715
2014 Q4	$3.39M	Sell	440,177 -2,303	-0.5%	-$18.2K	﹤0.01%	1657
2014 Q3	$3.31M	Buy	442,480 +3,279	+0.7%	+$30.4K	﹤0.01%	1637
2014 Q2	$4.25M	Sell	439,201 -4,789	-1%	-$42.7K	0.01%	1511
2014 Q1	$3.69M	Buy	443,990 +56,000	+14%	+$480K	0.01%	1600
2013 Q4	$3.27M	Sell	387,990 -10,603	-3%	-$89.4K	﹤0.01%	1662
2013 Q3	$3.18M	Buy	398,593 +26,489	+7%	+$213K	0.01%	1607
2013 Q2	$2.87M	Buy	+372,104	New	+$2.9M	0.01%	1585

Other funds holding PDLI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock Investment Management's PDLI Position: Q4 2016 in Review

BlackRock Investment Management reduced its PDL BioPharma, Inc. (PDLI) stake by 1.4% in Q4 2016, selling an estimated $27.4K and leaving 675,286 shares worth $1.43M. The position accounts for ﹤0.01% of the portfolio, ranked #2453.

BlackRock Investment Management first reported a position in PDLI in Q2 2013 and has held it in 15 quarters since. The position peaked at $4.25M in Q2 2014. 190 funds tracked by Wall St. Rank hold PDLI as of Q4 2016.

BlackRock Investment Management held 675,286 shares of PDL BioPharma, Inc. worth $1.43M as of Q4 2016.
BlackRock Investment Management sold 9,810 PDL BioPharma, Inc. shares in Q4 2016, an estimated $27.4K.
PDL BioPharma, Inc. made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2453 holding.
BlackRock Investment Management first reported a position in PDL BioPharma, Inc. in Q2 2013 and has held it in 15 quarters since.
BlackRock Investment Management's PDL BioPharma, Inc. position peaked at $4.25M in Q2 2014.
190 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.